Bluejay Diagnostics | 8-K:重大事件
Bluejay Diagnostics | SC 13G:超过5%持股股东披露文件-Anson Funds Management LP(5.1%),Anson Management GP LLC(5.1%)等
Bluejay Diagnostics | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Bluejay Diagnostics | 10-Q:2024财年三季报
Bluejay Diagnostics | 8-K:重大事件
Bluejay Diagnostics | 8-K:重大事件
Bluejay Diagnostics | DEFA14A:其他
Bluejay Diagnostics | DEF 14A:股东委托书决议
Bluejay Diagnostics | PRE 14A:并购重组委托声明
Bluejay Diagnostics | 8-K:重大事件
Bluejay Diagnostics | 8-K:重大事件
Bluejay Diagnostics | 10-Q:2024财年二季报
Bluejay Diagnostics | DEF 14A:股东委托书决议
Bluejay Diagnostics | PRE 14A:并购重组委托声明
Bluejay Diagnostics | SC 13G:超过5%持股股东披露文件-L1 Capital Global Opportunities Master Fund, Ltd.(9.99%)
Bluejay Diagnostics | 8-K:重大事件
Bluejay Diagnostics | 424B1:募资说明书
Bluejay Diagnostics | EFFECT:其他
Bluejay Diagnostics | CORRESP:信函
Bluejay Diagnostics | CORRESP:信函
暂无数据
暂无数据